Document ZJbYxrrR5Rax0pEyv87M9p9j0

-/} && -- iZl&O Ce: R. C. Buck - DuPont Chemical Solutions Enterprise P. O. Box 80402, ESL 402-5231 Wilmington, DE 19880-0402 OPPT Document Control Office EPA East, Room 6428 1201 Constitution Avenue, NW Washington, D. C. 20460 Attn : Mary Dominiak March 21, 2003 Dear Mary: Please find enclosed information describing DuPont's telomer-based products manufacturing locations in the United States which are part of the Telomer Research Program Characterizing Potential Release ofPFOA from Telomer-Based Product Manufacture described in the Voluntary Commitment, Item 3, on page 4 in the 14 March 2003 Letter of Intent submitted to the Agency by the Telomer Research Program of which DuPont is a member. This submission of information is non-CBI. As additional crossreference, this submission meets the commitment to provide this information to Agency as described in Appendix 5, page 15, March 2003, Item 3., "TRP Commitment Summary" of the Letter of Intent, which describes the specific timeline commitment for submission of information to the Agency. The locations of the DuPont telomer-based products manufacturing locations in the United States are as follows: Chambers Works in Deepwater, New Jersey Washington Works in Parkersburg, West Virginia Please contact me if you have any questions regarding this submission. Best regards. Stephen H. Korzeniowski Phone: 302.695.8672 Fax : 302.695.8680 Email : stephen.h.korzeniowski@usa.dupont.com HTAIN c B ' ooooo